Can the capsules be opened to access the dry powder
10.1126/scitranslmed.3007218 Summary Keywords gut hormones, bone metabolism, GIP, GLP-1, GLP-2, PYY, osteoporosis Citation Schiellerup SP, Skov-Jeppesen K, Windelv JA, Svane MS, Holst JJ, Hartmann B and Rosenkilde MM (2019) Gut Hormones and Their Effect on Bone Metabolism

Sergey Terushkin, MD, FACS Key Takeaways: Mounjaro (tirzepatide) targets GIP + GLP-1 receptors , while Ozempic (semaglutide) targets GLP-1 only Clinical studies show greater average weight loss with tirzepatide in many patients Both medications require BMI 30 or 27 with weight-related conditions Common side effects include nausea, GI discomfort, and appetite changes , usually improving with dose adjustment Insurance coverage varies more common for diabetes than weight loss Prescription required treatment must be doctor-guided and medically supervised If you are deciding between Mounjaro and Ozempic for weight loss in 2026, the key difference is that tirzepatide (Mounjaro) activates two metabolic pathways (GIP + GLP-1), while semaglutide (Ozempic) activates one (GLP-1) which may impact weight loss outcomes and tolerability

Research indicates a strong association between low vitamin D levels and alopecia areata, with studies showing significantly lower serum vitamin D concentrations in affected patients